Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of skin disorder across the globe
3.2.1.2 Growing adoption of outsourcing of manufacturing activities
3.2.1.3 Growing aging population
3.2.2 Industry pitfalls & challenges
3.2.2.1 Challenges in quality control
3.2.2.2 High capital investment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Semi-solid formulations
5.2.1 Creams
5.2.2 Ointments
5.2.3 Gels
5.2.4 Other semi-solid formulations
5.3 Liquid formulations
5.4 Transdermal patches
5.5 Solid formulations
Chapter 6 Market Estimates and Forecast, By Therapeutic Area, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Dermatology
6.3 Pain management
6.4 Wound care
6.5 Ophthalmology
6.6 Other therapeutic areas
Chapter 7 Market Estimates and Forecast, By Service Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Contract manufacturing
7.3 Contract development
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical companies
8.3 Biotechnology companies
8.4 Other end users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Ascenida Pharmaceuticals
10.2 Bora Pharmaceuticals
10.3 Cambrex
10.4 Contract Pharmaceuticals
10.5 DPT Laboratories
10.6 MedPharm
10.7 PCI Pharma Services
10.8 Pierre Fabre Group
10.9 Piramal Pharma Solutions
10.10 The Lubizol
